DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Sunday 23 August 2015

Smenamides A and B

.


Figure 1. Structures of smenamide A (1) and B (2).
Marinedrugs 11 04451 g001 1024



 Smenamide A (1)
 The positive ion mode high-resolution ESI mass spectrum of smenamide A (1)  displayed [M + H]+ and [M + Na]+ pseudomolecular ion peak at m/z 501.2508 and 523.2326, respectively. Both ions showed intense (32%) M + 2 isotope peaks, suggesting the presence of one atom of chlorine, and were indicative of the molecular formula C28H37ClN2O4 (calcd. 501.2515 for C28H38ClN2O4 and 523.2334 for C28H37ClN2O4Na). The peak at m/z 487.2557 ([M − HCl + Na]+) in the HRMS/MS spectrum confirmed the presence of chlorine in the molecule.


 Table 1. NMR data of smenamide A (1) (700 MHz, CD3OD).
Click here to display table


Smenamide A (1)

Colorless amorphous solid, HRESIMS (positive ion mode, MeOH) m/z 523.2326 ([M + Na]+, C28H37ClN2O4Na+, calcd. 532.2334), m/z 501.2509 ([M + Na]+, C28H38ClN2O4+, calcd. 501.2515); MS isotope pattern: M (100%), M + 1 (32%, calcd. 31.5%), M + 2 (37%, calcd. 36.0%), M + 3 (10%, calcd. 10.6%,); HRESIMS/MS (parent ion m/z 523.23, C28H37ClN2O4Na+): m/z 487.2557 (C28H36N2O4Na+, calcd. 487.2567), 397.2092 (C21H30N2O4Na+, calcd. 397.2098), 320.1384 (C16H24ClNO2Na+, calcd. 320.1388), 284.1618 (C16H23NO2Na+, calcd. 284.1621), 244.0941 (C12H15NO3Na+, calcd. 244.0944), 226.0836 (C12H13NO2Na+, calcd. 226.0838), 202.0472 (C9H9NO3Na+, calcd. 226.0475); 1H and 13C NMR: Table 1; UV (MeOH): λmax(ε) 287 nm (8200), 246 nm (46000), 225 nm (92000); CD (MeOH): λmax(Δε) 238 (+33), 219 (−30).


Smenamide B (2)

Colorless amorphous solid, HRESIMS (positive ion mode, MeOH) m/z 523.2320 ([M + Na]+, calcd. for C28H37ClN2O4Na+ 532.2334), m/z 501.2505 ([M + Na]+, calcd. for C28H38ClN2O4+ 501.2515); MS isotope pattern: M (100%), M + 1 (31%, calcd. 31.5%), M + 2 (36%, calcd. 36.0%), M + 3 (11%, calcd. 10.6%,); HRESIMS/MS (parent ion m/z 523.23, C28H37ClN2O4Na+): m/z 487.25567 (C28H36N2O4Na+, calcd. 487.2567), 397.2091 (C21H30N2O4Na+, calcd. 397.2098), 320.1383 (C16H24ClNO2Na+, calcd. 320.1388), 284.1617 (C16H23NO2Na+, calcd. 284.1621), 244.0941 (C12H15NO3Na+, calcd. 244.0944), 226.0835 (C12H13NO2Na+, calcd. 226.0838), 202.0471 (C9H9NO3Na+, calcd. 226.0475); 1H and 13C NMR: Table 1; 1H and 13C NMR: Supplementary Table S1; UV (MeOH): λmax(ε) 287 nm (15000), 248 nm (42000), 225 nm (84000); CD (MeOH): λmax(Δε) 237 (+7.3).




Mar. Drugs 2013, 11(11), 4451-4463; doi:10.3390/md11114451
Smenamides A and B, Chlorinated Peptide/Polyketide Hybrids Containing a Dolapyrrolidinone Unit from the Caribbean Sponge Smenospongia aurea. Evaluation of Their Role as Leads in Antitumor Drug Research
Roberta Teta 1, Elena Irollo 2, Gerardo Della Sala 1, Giuseppe Pirozzi 2, Alfonso Mangoni 1 and Valeria Costantino 1,*
1The NeaNat Group, Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, via D. Montesano 49, Napoli 80131, Italy; E-Mails: roberta.teta@unina.it (R.T.); gerardo.dellasala@unina.it (G.S.); alfonso.mangoni@unina.it (A.M.)
2Department of Experimental Oncology, Istituto Nazionale Tumori Fondazione “G. Pascale”, Via M. Semmola, Napoli 80131, Italy; E-Mails: e.irollo@istitutotumori.na.it (E.I.); g.pirozzi@istitutotumori.na.it (G.P.)
*Author to whom correspondence should be addressed; E-Mail: valeria.costantino@unina.it; Tel.: +39-081-678-504; Fax: +39-081-678-552.
Received: 27 September 2013; in revised form: 25 October 2013 / Accepted: 25 October 2013 /
Published: 8 November 2013

Abstract

: An in-depth study of the secondary metabolites contained in the Caribbean sponge Smenospongia aurea led to the isolation of smenamide A (1) and B (2), hybrid peptide/polyketide compounds containing a dolapyrrolidinone unit. Their structures were elucidated using high-resolution ESI-MS/MS and homo- and heteronuclear 2D NMR experiments. Structures of smenamides suggested that they are products of the cyanobacterial metabolism, and 16S rRNA metagenomic analysis detected Synechococcus spongiarum as the only cyanobacterium present in S. aurea. Smenamides showed potent cytotoxic activity at nanomolar levels on lung cancer Calu-1 cells, which for compound 1 is exerted through a clear pro-apoptotic mechanism. This makes smenamides promising leads for antitumor drug design.

//////

No comments:

Post a Comment